Juna V Konomi
Biographic Data
| ID | 8258664 |
|---|---|
| NAME | Juna V Konomi |
| GIVEN NAMES | Juna V |
| FAMILY NAME | Konomi |
| SIGNATURE | KONOMI J V |
| AFFILIATIONS | Emory University |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2018 |
| H-INDEX | 0 |
Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease
Mean ALT over 96 weeks is a reasonable proxy of histologic improvement of NASH and NASH + fibrosis. These findings support ALT as a valid monitoring biomarker of histologic change over time in children with NASH and fibrosis
Natural History of NAFLD Diagnosed in Childhood
Little is known regarding the subsequent course of non-alcoholic fatty liver disease (NAFLD) diagnosed in childhood. The objectives of this single-center study were to gather data on long-term health outcomes and to assess the feasibility of contacting former pediatric patients. In a large pediatric medical center, electronic records were searched to initially identify 162 former patients who had a liver biopsy between 2000 and 2010. Of these, 44…
No prominent works on this page.
Natural History of NAFLD Diagnosed in Childhood
Little is known regarding the subsequent course of non-alcoholic fatty liver disease (NAFLD) diagnosed in childhood. The objectives of this single-center study were to gather data on long-term health outcomes and to assess the feasibility of contacting former pediatric patients. In a large pediatric medical center, electronic records were searched to initially identify 162 former patients who had a liver biopsy between 2000 and 2010. Of these, 44…
Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease
Mean ALT over 96 weeks is a reasonable proxy of histologic improvement of NASH and NASH + fibrosis. These findings support ALT as a valid monitoring biomarker of histologic change over time in children with NASH and fibrosis
Disease (2 works) · Fatty liver (2 works) · Internal Medicine (2 works) · Liver Disease Diagnosis and Treatment (2 works) · Medicine (2 works) · Alanine aminotransferase (1 work) · Biology (1 work) · Biomarker (1 work) · Biopsy (1 work) · Diabetes mellitus (1 work)